Overview

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-10-30

Target enrollment:

Participant gender:

Summary

Pharmacokinetics and pharmacodynamics study of 3 formulations (human insulin enteric coated capsules 8mg vers. human insulin injection 5IU；human insulin enteric coated capsules 16mg vers. Human Insulin Injection 5IU) Relative biopotency and bioavailability of human insulin enteric coated capsules 8mg/16mg vers. human insulin injection 5IU

Phase:

PHASE1

Details

Lead Sponsor:

Shanghai Jiao Tong University School of Medicine

Treatments:

Insulin